Danaher Drops 4.31% Amid Analyst Downgrades

On April 7, 2025, Danaher's stock experienced a significant drop of 4.31% in pre-market trading, reflecting a notable decline in investor sentiment.

Several analysts have recently adjusted their ratings and price targets for Danaher. Robert W. Baird reduced their price target from $277.00 to $268.00 while maintaining an "overweight" rating. Guggenheim initiated coverage with a "buy" rating and a $275.00 target price. Barclays lowered their target price from $275.00 to $240.00 and set an "equal weight" rating. JPMorgan Chase & Co. decreased their price objective from $310.00 to $300.00, keeping an "overweight" rating. Citigroup also lowered their target price from $285.00 to $265.00 with a "buy" rating. Despite these adjustments, the consensus rating remains a "Moderate Buy" with an average target price of $278.24.

Danaher's recent financial performance includes meeting analysts' consensus estimates for earnings per share (EPS) at $2.14 for the last quarter. The company's dividend was also increased to $0.32 per share, marking a positive change from the previous quarter's dividend of $0.27. This represents an annualized dividend of $1.28 and a yield of 0.71%.

Insider trading activities have also been noted, with SVP Brian W. Ellis selling 5,700 shares at an average price of $224.13. Institutional investors have made adjustments to their stakes in Danaher, with some increasing their holdings while others reducing them. Overall, 79.05% of the stock is owned by institutional investors and hedge funds.